Screener
Pulse Biosciences, Inc. PLSE Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
FAQ
- What is Pulse Biosciences, Inc.'s operating lease liabilities (current)?
- Pulse Biosciences, Inc. (PLSE) reported operating lease liabilities (current) of $1.69M in Q2 2026.
- How has Pulse Biosciences, Inc.'s operating lease liabilities (current) changed year-over-year?
- Pulse Biosciences, Inc.'s operating lease liabilities (current) increased by 15.6% year-over-year, from $1.46M to $1.69M.
- What is the long-term trend for Pulse Biosciences, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s operating lease liabilities (current) has grown at a 23.7% compound annual growth rate (CAGR), from $542K to $1.57M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Pulse Biosciences, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude